Bitcoin ETFs hold over 1 million BTC, approaching 5% of total supply
Bitcoin ETFs, led by Grayscale and BlackRock, have amassed over 1 million BTC, nearing 5% of the total Bitcoin supply. The post Bitcoin ETFs hold over 1 million BTC, approaching 5% of total supply appeared first on Crypt...
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Bitcoin ETFs, led by Grayscale and BlackRock, have amassed over 1 million BTC, nearing 5% of the total Bitcoin supply.
The post Bitcoin ETFs hold over 1 million BTC, approaching 5% of total supply appeared first on Crypto Briefing.
Why this matters
This bitcoin story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on Crypto BriefingRelated market context
Bitcoin and Ether ETFs Attract $286 Million as Blackrock Funds Spark Broad Recovery
Crypto ETF flows opened the new week on a stronger footing, with bitcoin ETFs adding $265.69 million and ether ETFs bringing in $2...
Hyperscale Data buys 50.65 Bitcoin, pushing total holdings to 899.65 BTC
Hyperscale Data's aggressive Bitcoin accumulation strategy diversifies its investment portfolio, but increases exposure to market...
BlackRock put $209M behind Bitcoin’s rebound but can it last?
U.S. spot Bitcoin ETFs turned positive again on July 6, and the clearest question for Bitcoin is whether BlackRock's IBIT provided...
67 Million Americans Hold Crypto as Ripple Executive Pushes for CLARITY Act Rules
Key Takeaways: A new report by the National Cryptocurrency Association shows that one in four American adults now owns crypto. 67%...
Crypto infrastructure firm EDX Markets closes $76 million Series C led by SBI Holdings
EDX Markets' funding round highlights the increasing institutional demand for regulated crypto infrastructure, potentially reshapi...
Nasdaq arthritis company holding Moshe Hogeg crypto hits all-time low
As of 8:19am today in New York, every retail investor who had ever bought shares of Enlivex on the Nasdaq, an arthritis biotech-tu...